Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number

Overview of attention for article published in Biology Direct, February 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 987 followers.

New article: Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number https://t.co/vJon30xTdQ #prostatecancer #oncology https://t.co/nhqGLPBDsH

Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number https://t.co/Iy3xeFMx6r

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.